Evidence map›Paper›PMID 41152156›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Using memory recall response time on digital cognitive testing to detect subtle cognitive changes among cognitively unimpaired older adults.

Hairin Kim, Roos J Jutten, Daniel Soberanes, Mark A Dubbelman, Lia D'Aquila, Onyinye J Udeogu, Gad A Marshall, Keith A Johnson, Dorene M Rentz, Reisa A Sperling and 2 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hairin KimDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-9623-608X
Roos J JuttenAlzheimer Center Amsterdam, Department of Neurology, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, the Netherlands.
Daniel SoberanesDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mark A DubbelmanDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Lia D'AquilaDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Onyinye J UdeoguDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Gad A MarshallDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Keith A JohnsonDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Dorene M RentzDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Reisa A SperlingDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kathryn V PappDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Rebecca E AmariglioDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Funding

Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Hyun-Sik Yang · 2010 to 2026
$50.2M
Novel automated performance-based ADL outcomes for early AD clinical trialsR01AG053184 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI MARSHALL, GAD ASHER · 2018 to 2023
$4.5M
Characterizing the evolution of Subjective Cognitive Decline in preclinical Alzheimer's diseaseR01AG058825 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI AMARIGLIO, REBECCA E · 2019 to 2024
$4.0M
Ahead of the Curve: Early detection and monitoring of learning decrements in Alzheimers diseaseR01AG084017 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Kathryn Victoria Papp · 2024 to 2026
$2.5M
Davis Alzheimer Prevention Program and the Vettel Alzheimer Innovation FundNational Institutes of Health/National Institute on Aging 2P01AG036694-11NIA NIH HHS P01 AG036694NIA NIH HHS R01 AG053184NIA NIH HHS R01 AG058825NIA NIH HHS R01 AG084017NIH HHS AG058825-01A1NIH HHS R01AG053184
6 · The paper itself

Abstract

introductionWe investigated whether memory recall response time (RT) on remote digital testing reflects decrements in memory function linked to Alzheimer's disease (AD) biomarkers.

methodsOne hundred seventy-five cognitively unimpaired participants (age = 74.21 ± 8.33; 66.9% female) completed daily associative memory tests over 7 days. We examined how RT changed with repeated learning and how this related to accuracy. In a positron emission tomography-imaged subsample (n = 150), linear regression evaluated associations between mean RT across Days 1 to 3 and Days 5 to 7 and cortical amyloid and medial temporal and neocortical tau.

resultsRT for correct items progressively decreased, with a stronger RT-accuracy association observed on later learning days than at baseline. Moreover, even after accuracy plateaued, RT continued improving. Slower RT was associated with higher medial temporal tau but not with amyloid burden. DISCUSSION: Recall RT provides additional insight into AD-related learning decrements beyond accuracy alone. Slower RT in the memory recall task possibly reflects tau burden. HIGHLIGHTS: We examined recall response time (RT) changes over 7 days of repeated digital learning tasks. RT reveals learning-related changes even after accuracy plateaus. RT correlates with medial temporal tau and is moderated by age for neocortical tau. Digital RT data provide insights beyond accuracy, detecting subtle cognitive changes. RT may serve as a novel digital marker for preclinical Alzheimer's disease.

Indexed as

CognitionCognitive DysfunctionMental RecallNeuropsychological TestsReaction TimeAgedAged, 80 and overAlzheimer DiseaseFemaleHumansMalePositron-Emission Tomographytau Proteinstau ProteinsAlzheimer's diseasedigital cognitive testmemory consolidationresponse timetau pathology

Identifiers

PMID41152156
PMCPMC12568383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.